Intel upsizes its share sale to $20B — its first public equity raise since 1971

Intel upsized a common stock offering from $15B to $20B, pricing 210,526,315 shares at $95 for roughly $19.7B in net proceeds, with closing expected 12 August. The book drew more than $100B of institutional demand, about 5x oversubscribed. It is Intel's first public share sale since its 1971 IPO and one of the largest equity raises in US technology history. The money is earmarked for foundry expansion and AI-chip manufacturing; Intel has lifted 2026 capital-expenditure guidance above $20B from $18B, and its CFO has signalled a further increase in 2027. New shares dilute existing holders by about 4.9%.

Why it matters

Intel is buying time with someone else's money, and the market let it. A 5x book at $95 says investors will fund the foundry build-out on the AI thesis even while that foundry grew 31% last quarter and lost $2.1B doing it — the equity market is underwriting a turnaround the income statement has not yet shown. Reaching for public equity for the first time in 55 years also says something about the alternatives: after government stakes and strategic investments, this is the funding source with no strings and no partner attached, which matters when the capex line keeps rising and 2027 is guided higher again. The dilution is the honest cost, and it is small next to the risk being retired — Intel now has the balance sheet to keep building 14A capacity without a customer commitment forcing the schedule.

What to watch

Whether major external foundry customers sign after the raise, how 2027 capex guidance lands, and whether foundry losses narrow as the new capacity comes online.